When I read the post about the inefficiency of the biotech sector, my thought was "this is pretty much the same in all sectors, so why should biotech be any different?"
Most people are deeply inefficient and most companies seem to be set up in such a way as to make that even worse. I suspect the main reasons they survive anyways are some …
When I read the post about the inefficiency of the biotech sector, my thought was "this is pretty much the same in all sectors, so why should biotech be any different?"
Most people are deeply inefficient and most companies seem to be set up in such a way as to make that even worse. I suspect the main reasons they survive anyways are some combination of "economies of scale", "customer laziness" (it's amazing how little shopping around buyers seem to do in B2B), and "they're all doing it"...
Even tech startups, once they start growing, apparently import so many people with deeply ingrained corporatism that they become middle-management-infested bloat companies engaged mostly in reporting and meetings.
When I read the post about the inefficiency of the biotech sector, my thought was "this is pretty much the same in all sectors, so why should biotech be any different?"
Most people are deeply inefficient and most companies seem to be set up in such a way as to make that even worse. I suspect the main reasons they survive anyways are some combination of "economies of scale", "customer laziness" (it's amazing how little shopping around buyers seem to do in B2B), and "they're all doing it"...
Even tech startups, once they start growing, apparently import so many people with deeply ingrained corporatism that they become middle-management-infested bloat companies engaged mostly in reporting and meetings.